Neurodegenerative Diseases

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

Researchers report strong links between very high p‑tau217 levels and future cognitive decline yet say the test’s current accuracy only supports use in research and trials.